{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:33:22Z","timestamp":1791502402932,"version":"4.3.4"},"reference-count":175,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pathol.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T06:12:02Z","timestamp":1731564722000},"page":"178-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Current concepts and molecular pathology of neurodegenerative diseases"],"prefix":"10.1016","volume":"57","author":[{"given":"Shelley L.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-5511","authenticated-orcid":false,"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7880","key":"10.1016\/j.pathol.2024.10.006_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00281-013-0373-9","article-title":"The unfolded protein response in Alzheimer's disease","volume":"35","author":"Cornejo","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"16","key":"10.1016\/j.pathol.2024.10.006_bib3","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2174\/092986711795843236","article-title":"Removing protein aggregates: the role of proteolysis in neurodegeneration","volume":"18","author":"Nijholt","year":"2011","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00401-016-1565-x","article-title":"Dura mater is a potential source of Abeta seeds","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","article-title":"A\u00a0critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration","volume":"17","author":"Walsh","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nmeth0308-211","article-title":"Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking","volume":"5","author":"Atarashi","year":"2008","journal-title":"Nat Methods"},{"key":"10.1016\/j.pathol.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8820-4_2","article-title":"Ultrasensitive RT-QuIC seed amplification assays for disease-associated tau, alpha-synuclein, and prion aggregates","volume":"1873","author":"Saijo","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","article-title":"Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain","volume":"120","author":"Wakabayashi","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2018.12.031","article-title":"Tau immunoreactivity in peripheral tissues of human aging and select tauopathies","volume":"696","author":"Dugger","year":"2019","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00441-018-2851-9","article-title":"Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD?","volume":"373","author":"Orimo","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","article-title":"A\u00a0walk through tau therapeutic strategies","volume":"7","author":"Jadhav","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.pathol.2024.10.006_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101644","article-title":"Four-repeat tauopathies","author":"Rosler","year":"2019","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13311-015-0397-z","article-title":"Immunotherapeutic approaches targeting amyloid-beta, alpha-synuclein, and tau for the treatment of neurodegenerative disorders","volume":"13","author":"Valera","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pathol.2024.10.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108843","article-title":"Progress of immunotherapy of anti-alpha-synuclein in Parkinson's disease","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/14712598.2018.1543397","article-title":"Grasping at straws: the failure of solanezumab to modify mild Alzheimer's disease","volume":"18","author":"Doggrell","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.pathol.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1517\/14712598.2014.935332","article-title":"Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?","volume":"14","author":"Panza","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.pathol.2024.10.006_bib19","first-page":"837","article-title":"Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles","volume":"317","author":"Bancher","year":"1989","journal-title":"Prog Clin Biol Res"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","article-title":"Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain","volume":"6","author":"Kovacs","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe consortium experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"10.1016\/j.pathol.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-019-02035-7","article-title":"Cellular and regional vulnerability in frontotemporal tauopathies","volume":"138","author":"Forrest","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A\u00a0critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib27","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib28","first-page":"299","article-title":"Lewy body disease with and without dementia: a clinicopathological study of 35 cases","volume":"7","author":"Kosaka","year":"1988","journal-title":"Clin Neuropathol"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib29","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/archneur.61.12.1915","article-title":"Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions","volume":"61","author":"Popescu","year":"2004","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.pathol.2024.10.006_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2024.10.006_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","article-title":"Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread","volume":"69C","author":"Kovacs","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jnen\/nlw087","article-title":"Shared and distinct patterns of oligodendroglial response in alpha-synucleinopathies and tauopathies","volume":"75","author":"Rohan","year":"2016","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"10","key":"10.1016\/j.pathol.2024.10.006_bib34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","article-title":"Submandibular gland needle biopsy for the diagnosis of Parkinson disease","volume":"82","author":"Adler","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/NEN.0b013e3182805c72","article-title":"Submandibular gland biopsy for the diagnosis of Parkinson disease","volume":"72","author":"Beach","year":"2013","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2024.10.006_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","article-title":"Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects","volume":"571","author":"Beach","year":"2014","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease","volume":"119","author":"Del Tredici","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.pathol.2024.10.006_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Dis"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/NEN.0b013e3182801cde","article-title":"Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease","volume":"72","author":"Mu","year":"2013","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib41","first-page":"333","article-title":"Patterns of tau and alpha-synuclein pathology in the visual system","volume":"5","author":"Rahimi","year":"2015","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.pathol.2024.10.006_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2014.05.020","article-title":"Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread","volume":"69","author":"Kovacs","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bpa.12168","article-title":"The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies","volume":"25","author":"Seidel","year":"2015","journal-title":"Brain Pathol"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.26293","article-title":"Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy","volume":"30","author":"Doppler","year":"2015","journal-title":"Mov Dis"},{"issue":"10","key":"10.1016\/j.pathol.2024.10.006_bib45","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ene.12753","article-title":"Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature","volume":"23","author":"Schneider","year":"2016","journal-title":"Eur J Neurol"},{"issue":"Pt 8","key":"10.1016\/j.pathol.2024.10.006_bib47","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/brain\/awv138","article-title":"Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy","volume":"138","author":"Zange","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","article-title":"Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy","volume":"33","author":"Trojanowski","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"14","key":"10.1016\/j.pathol.2024.10.006_bib49","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.26052","article-title":"Neuropathology of multiple system atrophy: new thoughts about pathogenesis","volume":"29","author":"Jellinger","year":"2014","journal-title":"Mov Dis"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","article-title":"Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein","volume":"130","author":"Aoki","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00401-015-1455-7","article-title":"Screening for alpha-synuclein immunoreactive neuronal inclusions in the hippocampus allows identification of atypical MSA (FTLD-synuclein)","volume":"130","author":"Rohan","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/neup.12243","article-title":"Accumulation of phosphorylated alpha-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration","volume":"36","author":"Nakamura","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.pathol.2024.10.006_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-015-0208-0","article-title":"Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy","volume":"3","author":"Nakamura","year":"2015","journal-title":"Acta Neuropathologica Commun"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez-Valbuena","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","article-title":"\u03b1-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders","volume":"144","author":"Martinez-Valbuena","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1750-3639.1998.tb00158.x","article-title":"Pick's disease: a modern approach","volume":"8","author":"Dickson","year":"1998","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2990.2012.01272.x","article-title":"Neuropathology of the hippocampus in FTLD-tau with Pick bodies: a study of the BrainNet Europe consortium","volume":"39","author":"Kovacs","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","article-title":"Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy","volume":"144","author":"Roemer","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","article-title":"Globular glial tauopathies (GGT): consensus recommendations","volume":"126","author":"Ahmed","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"Suppl 2","key":"10.1016\/j.pathol.2024.10.006_bib60","first-page":"II6","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson","year":"1999","journal-title":"J\u00a0Neurol"},{"issue":"Pt 6","key":"10.1016\/j.pathol.2024.10.006_bib61","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-009-0531-2","article-title":"Hippocampal sclerosis with four-repeat tau-positive round inclusions in the dentate gyrus: a new type of four-repeat tauopathy","volume":"117","author":"Miki","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib63","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bpa.12482","article-title":"Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases","volume":"28","author":"Kovacs","year":"2018","journal-title":"Brain Pathol"},{"issue":"24","key":"10.1016\/j.pathol.2024.10.006_bib64","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0000000000201485","article-title":"Progressive supranuclear palsy syndrome associated with a novel tauopathy: case study","volume":"99","author":"Forrest","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/neup.12815","article-title":"An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes","volume":"42","author":"Suzuki","year":"2022","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00401-019-02119-4","article-title":"Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates","volume":"139","author":"Ling","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","article-title":"Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype","volume":"136","author":"Koga","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","article-title":"The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy","volume":"131","author":"McKee","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00401-023-02540-w","article-title":"Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts","volume":"145","author":"McKee","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.pathol.2024.10.006_bib70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnen\/nlac071","article-title":"Chronic traumatic encephalopathy in a routine neuropathology service in Australia","volume":"81","author":"Suter","year":"2022","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-023-02610-z","article-title":"Chronic traumatic encephalopathy in a female ex-professional Australian rules footballer","volume":"146","author":"Suter","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12792","article-title":"Classification of diseases with accumulation of Tau protein","volume":"48","author":"Kovacs","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib73","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2024.10.006_bib75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnagi.2020.00096","article-title":"Astroglia and tau: new perspectives","volume":"12","author":"Kovacs","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pathol.2024.10.006_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2015.00171","article-title":"Phenotypic heterogeneity of monogenic frontotemporal dementia. Review","volume":"7","author":"Benussi","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ng.293","article-title":"DCTN1 mutations in Perry syndrome","volume":"41","author":"Farrer","year":"2009","journal-title":"Nat Gen"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/neup.12233","article-title":"Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia","volume":"36","author":"Kovacs","year":"2016","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00401-013-1232-4","article-title":"The neuropathology associated with repeat expansions in the C9ORF72 gene","volume":"127","author":"Mackenzie","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.22244","article-title":"A\u00a0pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats","volume":"34","author":"van der Zee","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pathol.2024.10.006_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-014-1298-7","article-title":"Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration","volume":"128","author":"van der Zee","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.pathol.2024.10.006_bib83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/07853890.2012.665471","article-title":"The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum","volume":"44","author":"Van Langenhove","year":"2012","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","article-title":"Pallidonigral TDP-43 pathology in Perry syndrome","volume":"15","author":"Wider","year":"2009","journal-title":"Parkinsonism Rel Dis"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/neup.12051","article-title":"Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation","volume":"34","author":"Kamada","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.pathol.2024.10.006_bib86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dadm.2016.10.003","article-title":"The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: a longitudinal case report","volume":"6","author":"Koriath","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib87","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/neup.12138","article-title":"Significance and limitation of the pathological classification of TDP-43 proteinopathy","volume":"34","author":"Arai","year":"2014","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00401-010-0683-0","article-title":"Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord","volume":"120","author":"Braak","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","article-title":"TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions","volume":"171","author":"Cairns","year":"2007","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib91","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.pathol.2024.10.006_bib92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/nan.12250","article-title":"Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Review","volume":"41","author":"Lashley","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A\u00a0harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","article-title":"Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration","volume":"134","author":"Lee","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"7891","key":"10.1016\/j.pathol.2024.10.006_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","article-title":"Structure of pathological TDP-43 filaments from ALS with FTLD","volume":"601","author":"Arseni","year":"2022","journal-title":"Nature"},{"issue":"7975","key":"10.1016\/j.pathol.2024.10.006_bib96","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41586-023-06405-w","article-title":"TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP","volume":"620","author":"Arseni","year":"2023","journal-title":"Nature"},{"issue":"8034","key":"10.1016\/j.pathol.2024.10.006_bib97","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-024-08024-5","article-title":"Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C","volume":"634","author":"Arseni","year":"2024","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.pathol.2024.10.006_bib98","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1212\/01.wnl.0000472918.79256.a9","article-title":"The TMEM106B locus and TDP-43 pathology in older persons without FTLD","volume":"85","author":"Dickson","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib99","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-010-0658-1","article-title":"Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics","volume":"119","author":"Kovacs","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"10.1016\/j.pathol.2024.10.006_bib100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.pathol.2024.10.006_bib101","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/brain\/awr053","article-title":"Hippocampal sclerosis in advanced age: clinical and pathological features","volume":"134","author":"Nelson","year":"2011","journal-title":"Brain"},{"issue":"19","key":"10.1016\/j.pathol.2024.10.006_bib102","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s00018-015-1943-x","article-title":"The function of RNA-binding proteins at the synapse: implications for neurodegeneration","volume":"72","author":"Sephton","year":"2015","journal-title":"CMLS"},{"issue":"8","key":"10.1016\/j.pathol.2024.10.006_bib103","first-page":"1205","article-title":"Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases","volume":"256","author":"Geser","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib104","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12248","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"25","author":"McKee","year":"2015","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","article-title":"LATE-NC staging in routine neuropathologic diagnosis: an update","volume":"145","author":"Nelson","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.pathol.2024.10.006_bib108","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of Quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","article-title":"TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease","volume":"6","author":"Nag","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF00293396","article-title":"Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans","volume":"88","author":"Dickson","year":"1994","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-007-0331-5","article-title":"TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system","volume":"115","author":"Lee","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib112","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00401-009-0598-9","article-title":"FUS pathology in basophilic inclusion body disease","volume":"118","author":"Munoz","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"Pt 11","key":"10.1016\/j.pathol.2024.10.006_bib113","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/brain\/awp214","article-title":"A\u00a0new subtype of frontotemporal lobar degeneration with FUS pathology","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib114","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-009-0581-5","article-title":"Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease","volume":"118","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"Pt 9","key":"10.1016\/j.pathol.2024.10.006_bib115","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/brain\/awr201","article-title":"FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations","volume":"134","author":"Neumann","year":"2011","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/17530059.2011.576664","article-title":"Molecular diagnosis of human prion disease","volume":"5","author":"Quadrio","year":"2011","journal-title":"Exp Opin Med Diag"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib117","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","article-title":"Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA","volume":"124","author":"Parchi","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib119","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pathol.2024.10.006_bib120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","article-title":"Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification","volume":"118","author":"Parchi","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"19","key":"10.1016\/j.pathol.2024.10.006_bib121","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa030351","article-title":"Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease","volume":"349","author":"Glatzel","year":"2003","journal-title":"NEJM"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib122","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1167\/iovs.01-1273","article-title":"Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease","volume":"44","author":"Head","year":"2003","journal-title":"Inv Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib123","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","article-title":"Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study","volume":"164","author":"Head","year":"2004","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008765","article-title":"Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States","volume":"5","author":"Notari","year":"2010","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2006.050788","article-title":"Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease","volume":"168","author":"Peden","year":"2006","journal-title":"Am J Pathol"},{"issue":"Pt 3","key":"10.1016\/j.pathol.2024.10.006_bib126","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1099\/vir.0.81913-0","article-title":"Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease","volume":"88","author":"Peden","year":"2007","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.pathol.2024.10.006_bib127","series-title":"WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies","year":"2006"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0002-9440(10)65510-1","article-title":"Familial encephalopathy with neuroserpin inclusion bodies","volume":"155","author":"Davis","year":"1999","journal-title":"Am J Pathol"},{"issue":"6751","key":"10.1016\/j.pathol.2024.10.006_bib129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/43894","article-title":"Familial dementia caused by polymerization of mutant neuroserpin","volume":"401","author":"Davis","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/01.wnl.0000265052.99144.b5","article-title":"Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene. Case Reports","volume":"69","author":"Gourfinkel-An","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib131","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1750-3639.2011.00481.x","article-title":"Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene","volume":"21","author":"Hagen","year":"2011","journal-title":"Brain Pathol"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib132","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jnen\/59.12.1070","article-title":"Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy","volume":"59","author":"Takao","year":"2000","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib133","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/63.4.363","article-title":"Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene","volume":"63","author":"Vidal","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib134","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies","volume":"118","author":"Revesz","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib135","first-page":"87","article-title":"Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects","volume":"63","author":"Dickson","year":"1990","journal-title":"Lab Invest"},{"issue":"7909","key":"10.1016\/j.pathol.2024.10.006_bib136","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","article-title":"Age-dependent formation of TMEM106B amyloid filaments in human brains","volume":"605","author":"Schweighauser","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib137","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-022-02531-3","article-title":"Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging","volume":"145","author":"Perneel","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1016\/j.pathol.2024.10.006_bib138","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/aww214","article-title":"Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment","volume":"139","author":"Skrobot","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.pathol.2024.10.006_bib139","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2022.07.010","article-title":"Association of glial tau pathology and LATE-NC in the ageing brain","volume":"119","author":"Forrest","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pathol.2024.10.006_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106412","article-title":"Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC","volume":"191","author":"Katsumata","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020189","article-title":"Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine","volume":"17","author":"Kovacs","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib142","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series","volume":"126","author":"Kovacs","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2024.10.006_bib143","first-page":"1","article-title":"Current concepts of mixed pathologies in neurodegenerative diseases","author":"Forrest","year":"2022","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"10.1016\/j.pathol.2024.10.006_bib144","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"issue":"21","key":"10.1016\/j.pathol.2024.10.006_bib145","doi-asserted-by":"crossref","first-page":"e2472","DOI":"10.1212\/WNL.0000000000007530","article-title":"Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration","volume":"92","author":"Forrest","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.pathol.2024.10.006_bib146","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ene.14849","article-title":"Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis","volume":"28","author":"Forrest","year":"2021","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib147","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae141","article-title":"Multiple system atrophy with amyloid-\u03b2-predominant Alzheimer's disease neuropathologic change","volume":"6","author":"Kon","year":"2024","journal-title":"Brain Commun"},{"issue":"7","key":"10.1016\/j.pathol.2024.10.006_bib148","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.pathol.2024.10.006_bib149","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A\u00a0biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib151","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A\u00a0biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pathol.2024.10.006_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/mds.30028","article-title":"Biomarker-based approach to \u03b1-synucleinopathies: lessons from neuropathology","author":"Kovacs","year":"2024","journal-title":"Mov Disord"},{"issue":"7933","key":"10.1016\/j.pathol.2024.10.006_bib153","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of alpha-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib154","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/nan.12362","article-title":"Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type","volume":"43","author":"Brettschneider","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7825","key":"10.1016\/j.pathol.2024.10.006_bib156","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pathol.2024.10.006_bib157","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnen\/nly080","article-title":"Converging patterns of alpha-synuclein pathology in multiple system atrophy","volume":"77","author":"Brettschneider","year":"2018","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"11","key":"10.1016\/j.pathol.2024.10.006_bib158","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib159","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.pathol.2024.10.006_bib161","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","article-title":"Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold","volume":"136","author":"Falcon","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"7662","key":"10.1016\/j.pathol.2024.10.006_bib162","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pathol.2024.10.006_bib163","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"6577","key":"10.1016\/j.pathol.2024.10.006_bib164","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-beta 42 filaments from human brains","volume":"375","author":"Yang","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pathol.2024.10.006_bib165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24559","article-title":"Deep clinical and neuropathological phenotyping of Pick disease","volume":"79","author":"Irwin","year":"2016","journal-title":"Ann Neurol"},{"issue":"7721","key":"10.1016\/j.pathol.2024.10.006_bib166","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick's disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.pathol.2024.10.006_bib167","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1002\/cne.23430","article-title":"Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases","volume":"521","author":"Arnold","year":"2013","journal-title":"J\u00a0Comp Neurol"},{"issue":"7802","key":"10.1016\/j.pathol.2024.10.006_bib168","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pathol.2024.10.006_bib169","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnen\/63.9.911","article-title":"Staging of argyrophilic grains: an age-associated tauopathy","volume":"63","author":"Saito","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib170","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.pathol.2024.10.006_bib171","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","article-title":"Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)","volume":"127","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pathol.2024.10.006_bib172","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.pathol.2024.10.006_bib173","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer's disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"8\u20139","key":"10.1016\/j.pathol.2024.10.006_bib174","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s007020050096","article-title":"Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria","volume":"105","author":"Braak","year":"1998","journal-title":"J\u00a0Neural Transm"},{"issue":"6","key":"10.1016\/j.pathol.2024.10.006_bib175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","article-title":"Argyrophilic grain disease is a sporadic 4-repeat tauopathy","volume":"61","author":"Togo","year":"2002","journal-title":"J\u00a0Neuropathol Exp Neurol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:52:08Z","timestamp":1738371128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302524002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0031302524002976"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2024.10.006","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts and molecular pathology of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}